Case report: AREB in a patient with rheumatoid arthritis treated with methotrexate and infliximab

被引：1

作者：

D'Alessandro, Giuseppe ^{[1
]}

Bianco, Maria Rosaria ^{[1
]}

Politis, Spiridion ^{[1
]}

Ferrandina, Celestino ^{[2
]}

Rossi, Giuseppe ^{[1
]}

Altomare, Emanuele ^{[1
]}

机构：

[1] II Med Interna Univ, Foggia, Italy

[2] Univ Foggia, Azienda Osped Univ Osped Riuniti, Ematol Osped, Foggia, Italy

来源：

REUMATISMO | 2006年 / 58卷 / 01期

关键词：

Rheumatoid arthritis; infliximab; methotrexate;

D O I：

10.4081/reumatismo.2006.59

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Anti TNF-alpha drugs seem to be the new frontier of Rheumatoid Arthritis (RA) therapy. The association infliximab methotrexate has been approved for the treatment of RA not responding to the classic therapy, but the short clinical experience in using antiTNF-alpha molecules brings to segnalation of new risks or adverse events. We describe a case of a patient, treated for many years with classic RA therapy, which developed a refractory anemia after treatment with association infliximab-methotrexate.

引用

页码：59 / 61

页数：3

共 10 条

[1]

Baraliakos X, 2004, ARTHRITIS RHEUM, V50, pS217

[2]

Calvo Romero JM, 2001, ANN PHORMACOTER, V35, P1575

[3] Adverse reactions to TNF-α inhibitors in rheumatoid arthritis [J].